Innovation

EpiBiologics: $107 Million Series B Raised To Advance Tissue-Selective EGFR Degrader And Bispecific Antibody Pipeline

By Amit Chowdhry ● Jan 10, 2026

EpiBiologics announced it has closed a $107 million Series B financing to advance a pipeline of bispecific antibodies designed to selectively degrade extracellular protein targets in oncology and immunology. The round was co-led by GV and Johnson & Johnson, through Johnson & Johnson Innovation – JJDC, with participation from new and existing investors.

Domaine Buys Digital Design Agency Pattern

By Amit Chowdhry ● Jan 10, 2026

Domaine Worldwide, a global Shopify design and development firm, has acquired Pattern, an award-winning digital design agency focused on commerce brands, as the combined company aims to deliver “experience-first” digital commerce at scale.

Collaboration.Ai Acquires innosabi To Expand AI-Based Innovation Management Platform

By Amit Chowdhry ● Jan 10, 2026

Collaboration.Ai, an AI-based software and services company, said it has acquired innosabi GmbH, a global innovation management provider, in a move aimed at building a more connected platform that helps organizations move from early insight to execution across the full innovation lifecycle. Financial terms were not disclosed.

Vanda And Exante Data Merge To Build Expanded Macro Analytics Platform

By Amit Chowdhry ● Jan 10, 2026

Vanda and Exante Data announced they have entered into and completed a definitive merger agreement in which Vanda will acquire all outstanding capital stock of Exante Data, bringing the macro strategy and capital-flow analytics provider into the Vanda platform. Financial terms were not disclosed.

Sam’s Caribbean Marketplace: Interview With Founder Andrew Morris About Merging Tradition With Tech

By Amit Chowdhry ● Jan 10, 2026

Sam's Caribbean Marketplace is a restaurant and specialty store in West Hempstead, NY, that sells a wide variety of Caribbean food and other products, including groceries, herbs, spices, and hot meals. Pulse 2.0 interviewed Sam's Caribbean Marketplace founder, Andrew Morris, to gain a deeper understanding of the company.

32 Biosciences: $40M Series A Launched To Advance GI Mucosal-Immune Therapeutics

By Amit Chowdhry ● Jan 10, 2026

32 Biosciences, a gastrointestinal-focused biotechnology company, announced it will launch a $40 million Series A financing during the 2026 J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026.

BrightHeart: €11 Million Series A Raised To Expand Prenatal Ultrasound AI Platform

By Amit Chowdhry ● Jan 10, 2026

BrightHeart, a Paris-based developer of AI software for prenatal ultrasound, said it has closed an €11 million Series A financing to fund U.S. commercialization, broader European expansion and continued product development for its B-Right AI Platform.

Spangle AI: $15 Million Series A Closed To Build Agentic Infrastructure For Commerce

By Amit Chowdhry ● Jan 10, 2026

Spangle AI, an agentic infrastructure layer for commerce, said it raised a $15 million Series A round led by NewRoad Capital Partners with participation from Madrona, DNX Ventures, Streamlined Ventures, and strategic angel investors, bringing total funding to $21 million.

Luxury Presence: $37 Million Raised To Advance Presence CRM, An AI Relationship Engine For Real Estate Agents

By Amit Chowdhry ● Jan 10, 2026

Luxury Presence, a growth platform used by more than 87,000 residential real estate agents and brands, announced it raised $37 million in new capital to accelerate the development and launch of Presence CRM, which it is positioning as an AI-driven system designed to surface deal opportunities from an agent’s existing network.

SocraticX: Interview With Founder Memo Ozdogan About The Decision-Making Platform

By Amit Chowdhry ● Jan 10, 2026

SocraticX builds an AI-driven platform that helps companies automate complex decision-making and operational workflows using structured reasoning models. Pulse 2.0 interviewed SocraticX founder Memo Ozdogan to gain a deeper understanding of the company.

Enodia Therapeutics: €20.7 Million Seed Funding Closed To Advance SEC61-Based Small-Molecule Protein Degradation Platform

By Amit Chowdhry ● Jan 10, 2026

Enodia Therapeutics has raised €20.7 million (about $25 million) in a seed financing to advance a discovery platform that uses proteomics and machine learning to develop small molecules that degrade disease-driving proteins at the point of synthesis. The round was co-led by Elaia, Pfizer Ventures, and Bpifrance as part of its InnoBio investment strategy, with participation from Wallonie Entreprendre, Argobio Studio, MACSF, The Institut Pasteur, InvestSud, Sambrinvest, and Mission BioCapital.

SonoThera: $125 Million Series B Raised To Advance Ultrasound-Mediated Genetic Medicines Toward First-In-Human Trials

By Amit Chowdhry ● Jan 10, 2026

SonoThera announced it will officially launch a $125 million Series B funding round at the 44th annual J.P. Morgan Healthcare Conference in San Francisco, scheduled for January 12–15, 2026, as the company looks to advance multiple genetic medicine programs toward first-in-human studies.